首页> 外文期刊>Journal of Ophthalmic Inflammation and Infection >Pharmacokinetics of intravitreal antibiotics in endophthalmitis
【24h】

Pharmacokinetics of intravitreal antibiotics in endophthalmitis

机译:玻璃体内抗生素治疗眼内炎的药代动力学

获取原文
           

摘要

Intravitreal antibiotics are the mainstay of treatment in the management of infectious endophthalmitis. Basic knowledge of the commonly used intravitreal antibiotics, which includes their pharmacokinetics, half-life, duration of action and clearance, is essential for elimination of intraocular infection without any iatrogenic adverse effect to the ocular tissue. Various drugs have been studied over the past century to achieve this goal. We performed a comprehensive review of the antibiotics which have been used for intravitreal route and the pharmacokinetic factors influencing the drug delivery and safety profile of these antibiotics. Using online resources like PubMed and Google Scholar, articles were reviewed. The articles were confined to the English language only. We present a broad overview of pharmacokinetic concepts fundamental for use of intravitreal antibiotics in endophthalmitis along with a tabulated compendium of the intravitreal antibiotics using available literature. Recent advances for increasing bioavailability of antibiotics to the posterior segment with the development of controlled drug delivery devices are also described.
机译:玻璃体内抗生素是控制传染性眼内炎的主要治疗手段。常用的玻璃体内抗生素的基本知识(包括其药代动力学,半衰期,作用时间和清除率)对于消除眼内感染,对眼组织没有任何医源性不良影响至关重要。在过去的一个世纪中,已经研究了各种药物来实现这一目标。我们对玻璃体内途径使用的抗生素以及影响这些抗生素的给药和安全性的药代动力学因素进行了全面综述。使用PubMed和Google Scholar等在线资源,对文章进行了评论。文章仅限于英语。我们使用现有文献对玻璃体内抗生素在眼内炎中使用的基本药物动力学概论进行了概述,并列出了玻璃体内抗生素一览表。还描述了随着受控药物递送装置的发展而增加对后段的抗生素的生物利用度的最新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号